Arvind Utchanah
Director of Finance/CFO bei KNIGHT THERAPEUTICS INC.
Vermögen: 153 413 $ am 31.03.2024
Aktive Positionen von Arvind Utchanah
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KNIGHT THERAPEUTICS INC. | Director of Finance/CFO | 30.03.2020 | - |
| Public Communications Contact | - | - | |
| Corporate Officer/Principal | 20.06.2016 | 30.03.2020 |
Karriereverlauf von Arvind Utchanah
Ehemalige bekannte Positionen von Arvind Utchanah
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PALADIN LABS INC. | Comptroller/Controller/Auditor | 01.01.2012 | 01.06.2016 |
| Director of Finance/CFO | 01.01.2012 | 01.06.2016 |
Ausbildung von Arvind Utchanah
| McGill University | Undergraduate Degree |
| Concordia University | Graduate Degree |
Statistik
International
| Kanada | 5 |
Operativ
| Director of Finance/CFO | 2 |
| Public Communications Contact | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KNIGHT THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Paladin Labs, Inc.
 Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Paladin Labs Inc. operates as pharmaceutical company. It engages in developing, acquiring, in-licensing, marketing, and distributing innovative pharmaceutical products in Canada and internationally. The firm's products include Abstral, GlucaGen, Metadol, Plan B, Pennsaid, Seasonale, Testim, Twinject, Dexedrin, Tridural, and Trelstar. The company was founded by Jonathan Ross Goodman and Mark Beaudet on February 25, 1983 and is headquartered in Montreal, Canada. | Health Technology |
- Börse
- Insiders
- Arvind Utchanah
- Erfahrung
